Index - P/E - EPS (ttm) -3.80 Insider Own 6.33% Shs Outstand 119.58M Perf Week 5.80%
Market Cap 11.85B Forward P/E - EPS next Y -1.19 Insider Trans -15.63% Shs Float 114.51M Perf Month 5.00%
Income -434.80M PEG - EPS next Q -0.71 Inst Own 91.28% Short Float 5.03% Perf Quarter 43.19%
Sales 1.08B P/S 10.95 EPS this Y 38.74% Inst Trans 1.75% Short Ratio 4.20 Perf Half Y 144.34%
Book/sh 6.40 P/B 15.15 EPS next Y 48.70% ROA -30.28% Short Interest 5.76M Perf Year 86.00%
Cash/sh 7.19 P/C 13.49 EPS next 5Y - ROE -59.11% 52W Range 36.90 - 98.82 Perf YTD 54.82%
Dividend Est. - P/FCF - EPS past 5Y -11.28% ROI -38.99% 52W High -1.86% Beta 1.50
Dividend TTM - Quick Ratio 3.96 Sales past 5Y 33.95% Gross Margin 45.52% 52W Low 162.82% ATR (14) 3.39
Dividend Ex-Date - Current Ratio 4.10 EPS Y/Y TTM 31.79% Oper. Margin -41.22% RSI (14) 63.46 Volatility 3.56% 3.58%
Employees 3293 Debt/Eq 0.58 Sales Y/Y TTM 31.99% Profit Margin -40.16% Recom 1.50 Target Price 103.89
Option/Short Yes / Yes LT Debt/Eq 0.46 EPS Q/Q 52.15% Payout - Rel Volume 0.69 Prev Close 93.72
Sales Surprise 3.70% EPS Surprise 15.57% Sales Q/Q 43.20% Earnings May 09 AMC Avg Volume 1.37M Price 96.98
SMA20 4.85% SMA50 8.21% SMA200 53.56% Trades
Volume 939,653 Change 3.48%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-24 Resumed Craig Hallum
Buy
$117
Feb-20-24 Downgrade Raymond James
Strong Buy → Outperform
$68 → $85
Dec-29-23 Reiterated BTIG Research
Buy
$75 → $85
Dec-14-23 Initiated Guggenheim
Buy
$70
Dec-13-23 Initiated Wolfe Research
Outperform
$70
Nov-13-23 Upgrade Raymond James
Outperform → Strong Buy
$68
Sep-28-23 Initiated Bernstein
Mkt Perform
$48
Jul-05-23 Resumed JP Morgan
Overweight
$85
May-05-23 Initiated UBS
Buy
$76
Jan-18-23 Upgrade Raymond James
Mkt Perform → Outperform
$58
Aug-25-22 Initiated Credit Suisse
Outperform
$70
Apr-25-22 Initiated Stephens
Overweight
$54
Mar-08-22 Initiated Goldman
Buy
$90
Jan-06-22 Resumed Piper Sandler
Overweight
$110
Oct-15-21 Resumed Cowen
Outperform
$150
Jun-15-21 Initiated Raymond James
Mkt Perform
May-25-21 Initiated Wells Fargo
Overweight
$110
Jan-28-21 Initiated Truist
Buy
$143
Oct-08-20 Initiated BTIG Research
Buy
$90
Sep-28-20 Initiated Morgan Stanley
Overweight
$80
Show Previous Ratings
Today 08:00AM
May-02-24 02:14PM
02:50AM
02:49AM
May-01-24 04:05PM
07:00AM
Loading…
07:00AM
Apr-27-24 02:42AM
Apr-26-24 06:32PM
Apr-24-24 08:36AM
02:38AM
02:38AM
Apr-22-24 08:00AM
Apr-18-24 02:05AM
Apr-17-24 08:31AM
Apr-11-24 08:00AM
07:37AM
Loading…
Apr-09-24 07:37AM
Apr-08-24 08:00AM
Apr-05-24 07:00AM
05:15AM
01:51AM
Apr-01-24 08:00AM
Mar-21-24 10:25AM
Mar-20-24 05:46AM
Mar-18-24 03:39PM
(Investor's Business Daily)
07:00AM
Mar-14-24 08:00AM
Mar-12-24 08:00AM
Mar-11-24 02:22PM
Mar-08-24 01:31AM
Mar-07-24 08:00AM
12:00PM
Loading…
Mar-04-24 12:00PM
Mar-01-24 12:09AM
Feb-29-24 11:06AM
(Thomson Reuters StreetEvents) +12.98%
08:12AM
08:00AM
Feb-28-24 06:30PM
04:32PM
04:05PM
Feb-27-24 08:12AM
08:00AM
01:07AM
Feb-26-24 07:00AM
Feb-20-24 08:00AM
Feb-17-24 12:07AM
Feb-06-24 04:00PM
Feb-05-24 08:00AM
Feb-02-24 11:02PM
Jan-31-24 05:02PM
Jan-30-24 09:15AM
07:00AM
Jan-29-24 07:00AM
Jan-25-24 07:00AM
Jan-24-24 12:20AM
Jan-22-24 07:00AM
07:00AM
Jan-18-24 08:00AM
Jan-17-24 04:03PM
(Investor's Business Daily) +7.30%
Jan-16-24 05:17PM
Jan-09-24 07:00AM
Dec-30-23 11:01AM
Dec-29-23 08:00AM
Dec-27-23 11:48PM
Dec-26-23 06:56PM
Dec-21-23 08:00AM
Dec-11-23 12:50PM
Dec-10-23 11:59AM
Dec-06-23 08:30AM
Dec-02-23 07:06AM
Nov-23-23 11:03AM
Nov-14-23 08:00AM
Nov-13-23 11:24AM
Nov-08-23 05:02PM
(Associated Press Finance) -5.27%
04:05PM
09:10AM
Nov-07-23 08:30AM
Nov-02-23 08:30AM
Oct-25-23 09:02AM
Oct-22-23 01:00PM
Oct-20-23 09:00AM
Oct-19-23 09:00AM
Oct-17-23 09:15AM
Oct-16-23 09:00AM
Oct-04-23 09:00AM
Oct-03-23 04:43PM
Oct-02-23 09:00AM
Sep-30-23 05:01AM
Sep-18-23 09:00AM
Sep-14-23 07:37PM
09:00AM
Sep-07-23 12:09AM
Sep-06-23 04:24PM
Sep-05-23 10:09AM
Sep-04-23 12:17PM
Sep-01-23 09:00AM
Aug-18-23 07:39AM
Aug-16-23 09:00AM
Aug-11-23 01:37PM
(Investor's Business Daily) +5.38%
Aug-05-23 06:27AM
Aug-04-23 11:15AM
06:58AM
(Thomson Reuters StreetEvents)
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Chapman Steven Leonard CEO AND PRESIDENT Apr 29 '24 Sale 93.14 4,084 380,378 226,235 May 01 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 29 '24 Sale 93.14 1,238 115,306 69,408 May 01 09:05 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 29 '24 Sale 93.14 1,196 111,394 115,833 May 01 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Apr 29 '24 Sale 93.14 1,057 98,448 204,495 May 01 09:05 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Apr 29 '24 Sale 93.14 929 86,526 110,748 May 01 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 26 '24 Sale 92.00 751 69,092 70,646 Apr 26 09:35 PM Sheena Jonathan CO-FOUNDER Apr 25 '24 Sale 89.55 1,000 89,550 69,082 Apr 26 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 25 '24 Sale 89.55 705 63,133 71,397 Apr 26 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 24 '24 Sale 93.00 937 87,140 72,102 Apr 26 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Apr 23 '24 Sale 91.38 2,552 233,200 230,319 Apr 23 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 23 '24 Sale 91.38 1,523 139,171 73,039 Apr 23 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Apr 23 '24 Sale 91.38 787 71,915 205,552 Apr 23 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 23 '24 Sale 91.38 531 48,522 117,029 Apr 23 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Apr 23 '24 Sale 91.38 522 47,700 111,677 Apr 23 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 16 '24 Sale 90.82 80,000 7,265,651 117,560 Apr 17 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Apr 15 '24 Sale 93.13 6,816 634,797 227,710 Apr 17 09:05 PM Sheena Jonathan CO-FOUNDER Apr 03 '24 Sale 92.47 26,700 2,468,822 321,031 Apr 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 02 '24 Sale 92.62 1,378 127,629 70,646 Apr 04 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 28 '24 Sale 90.42 2,662 240,687 234,526 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 28 '24 Sale 90.13 1,000 90,130 69,582 Mar 29 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Mar 28 '24 Sale 90.42 914 82,640 72,024 Mar 29 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Mar 28 '24 Sale 90.42 743 67,179 204,839 Mar 29 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Mar 28 '24 Sale 90.42 707 63,924 197,560 Mar 29 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Mar 28 '24 Sale 90.42 464 41,953 112,199 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 28 '24 Sale 90.22 447 40,326 347,731 Mar 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Option Exercise 19.37 68,270 1,322,406 315,227 Mar 15 09:05 PM BOTHA ROELOF Director Mar 15 '24 Option Exercise 42.17 19,924 840,197 20,276 Mar 15 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Sale 88.96 83,223 7,403,534 232,004 Mar 15 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Sale 89.02 50,910 4,532,065 0 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 06 '24 Sale 88.70 5,000 443,492 458,585 Mar 07 09:40 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Mar 05 '24 Sale 87.40 190,000 16,605,069 860,036 Mar 07 09:40 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 05 '24 Sale 88.36 9,326 824,092 246,957 Mar 07 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Mar 05 '24 Sale 88.36 2,826 249,719 70,646 Mar 07 09:40 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Mar 05 '24 Sale 88.36 2,245 198,361 198,267 Mar 07 09:40 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Mar 05 '24 Sale 88.36 2,160 190,868 204,218 Mar 07 09:40 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Mar 05 '24 Sale 88.36 1,838 162,400 112,663 Mar 07 09:40 PM Sheena Jonathan CO-FOUNDER Mar 05 '24 Sale 88.36 1,028 90,839 463,585 Mar 07 09:40 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Mar 05 '24 Sale 88.36 1,012 89,416 1,075,648 Mar 07 09:40 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 29 '24 Option Exercise 9.29 20,526 190,687 224,744 Feb 29 09:15 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 29 '24 Sale 89.01 20,526 1,826,970 204,218 Feb 29 09:15 PM Sheena Jonathan CO-FOUNDER Feb 29 '24 Sale 86.34 10,000 863,433 463,585 Mar 01 08:45 PM Sheena Jonathan CO-FOUNDER Feb 29 '24 Sale 90.02 6,000 540,109 14,655 Mar 01 08:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 27 '24 Option Exercise 10.16 35,307 358,802 239,525 Feb 29 09:15 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 27 '24 Sale 75.09 35,307 2,651,298 204,218 Feb 29 09:15 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Feb 23 '24 Option Exercise 2.66 380,036 1,009,718 1,050,036 Feb 23 09:40 PM ROSENMAN HERM Director Feb 16 '24 Option Exercise 2.66 93,901 249,486 155,586 Feb 16 09:45 PM ROSENMAN HERM Director Feb 16 '24 Sale 69.37 93,901 6,514,371 61,685 Feb 16 09:45 PM Sheena Jonathan CO-FOUNDER Feb 07 '24 Sale 70.10 5,000 350,486 473,585 Feb 08 09:05 PM Sheena Jonathan CO-FOUNDER Feb 07 '24 Sale 70.10 1,000 70,099 17,655 Feb 08 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 06 '24 Option Exercise 16.61 34,029 565,063 104,675 Feb 08 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 06 '24 Sale 70.03 34,029 2,383,129 70,646 Feb 08 09:40 PM Sheena Jonathan CO-FOUNDER Feb 06 '24 Sale 70.00 6,000 420,011 18,155 Feb 08 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 01 '24 Sale 67.73 22,281 1,509,081 70,646 Feb 02 09:40 PM Chapman Steven Leonard CEO AND PRESIDENT Jan 29 '24 Sale 65.09 14,813 964,194 246,957 Jan 30 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Jan 29 '24 Sale 65.09 4,265 277,614 204,218 Jan 30 09:05 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Jan 29 '24 Sale 65.09 3,426 223,002 194,977 Jan 30 09:02 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 29 '24 Sale 65.09 3,235 210,570 92,927 Jan 30 09:15 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Jan 29 '24 Sale 65.09 2,358 153,485 108,494 Jan 30 08:57 PM Sheena Jonathan CO-FOUNDER Jan 29 '24 Sale 65.09 546 35,540 478,585 Jan 30 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 24 '24 Sale 67.00 944 63,248 64,810 Jan 26 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 23 '24 Sale 65.86 2,202 145,014 65,754 Jan 23 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Jan 22 '24 Sale 68.16 1,958 133,457 175,550 Jan 23 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Jan 22 '24 Sale 68.16 892 60,799 181,050 Jan 23 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 22 '24 Sale 68.16 771 52,551 67,956 Jan 23 09:45 PM Sheena Jonathan CO-FOUNDER Jan 22 '24 Sale 68.16 351 23,924 469,726 Jan 23 09:05 PM Sheena Jonathan CO-FOUNDER Jan 03 '24 Sale 60.30 5,000 301,499 469,743 Jan 05 08:05 PM Sheena Jonathan CO-FOUNDER Jan 03 '24 Sale 60.45 1,000 60,451 21,155 Jan 05 08:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Dec 29 '23 Sale 62.29 1,377 85,773 64,810 Dec 29 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Dec 28 '23 Sale 63.29 2,604 164,813 172,348 Dec 29 09:35 PM Sheena Jonathan CO-FOUNDER Dec 28 '23 Sale 62.12 1,000 62,120 21,655 Dec 29 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Dec 28 '23 Sale 63.29 915 57,912 66,187 Dec 29 09:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Dec 28 '23 Sale 63.29 728 46,077 180,442 Dec 29 09:05 PM Sheena Jonathan CO-FOUNDER Dec 28 '23 Sale 62.44 447 27,909 474,743 Dec 29 09:05 PM HEALY JAMES Director Dec 13 '23 Sale 58.75 644,000 37,835,000 0 Dec 22 02:21 PM Marcus Gail Boxer Director Dec 08 '23 Sale 57.52 500 28,760 20,146 Dec 12 08:35 PM Sheena Jonathan CO-FOUNDER Dec 06 '23 Sale 58.22 5,000 291,078 474,743 Dec 08 08:35 PM Chapman Rowan E Director Nov 29 '23 Sale 55.97 1,998 111,831 9,373 Dec 01 08:35 PM Marcus Gail Boxer Director Nov 21 '23 Sale 54.31 1,000 54,314 20,646 Nov 22 08:05 PM Chapman Steven Leonard CEO AND PRESIDENT Nov 20 '23 Sale 55.00 2,566 141,130 217,554 Nov 22 08:05 PM Sheena Jonathan CO-FOUNDER Nov 02 '23 Sale 40.23 5,000 201,150 479,743 Nov 03 09:05 PM Sheena Jonathan CO-FOUNDER Nov 02 '23 Sale 40.35 1,000 40,351 22,155 Nov 03 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 23 '23 Sale 40.40 3,940 159,195 64,810 Oct 24 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Oct 23 '23 Sale 40.39 2,595 104,813 220,120 Oct 24 09:35 PM Sheena Jonathan CO-FOUNDER Oct 23 '23 Sale 40.04 1,000 40,037 22,655 Oct 24 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Oct 23 '23 Sale 40.39 803 32,433 179,807 Oct 24 09:05 PM Sheena Jonathan CO-FOUNDER Oct 23 '23 Sale 40.19 335 13,464 484,743 Oct 24 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sep 29 '23 Sale 45.98 1,372 63,080 64,833 Sep 29 09:45 PM Sheena Jonathan CO-FOUNDER Sep 28 '23 Sale 46.06 5,448 250,909 484,745 Sep 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Sep 28 '23 Sale 45.82 2,617 119,901 217,554 Sep 29 09:45 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sep 28 '23 Sale 45.82 919 42,105 66,205 Sep 29 09:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sep 28 '23 Sale 45.82 732 33,537 179,110 Sep 29 09:35 PM Sheena Jonathan CO-FOUNDER Sep 06 '23 Sale 59.07 5,000 295,365 489,746 Sep 08 09:05 PM Sheena Jonathan CO-FOUNDER Sep 06 '23 Sale 59.23 1,000 59,227 23,155 Sep 08 09:05 PM Sheena Jonathan CO-FOUNDER Sep 01 '23 Sale 60.01 10,000 600,062 494,746 Sep 01 09:30 PM Chapman Steven Leonard CEO AND PRESIDENT Aug 11 '23 Sale 55.00 2,578 141,790 214,988 Aug 14 09:05 PM Sheena Jonathan CO-FOUNDER Aug 02 '23 Sale 44.22 5,000 221,116 504,746 Aug 04 09:35 PM Sheena Jonathan CO-FOUNDER Aug 02 '23 Sale 44.15 1,000 44,149 23,655 Aug 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jul 25 '23 Sale 46.58 2,347 109,323 64,833 Jul 27 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Jul 24 '23 Sale 47.83 2,578 123,296 217,566 Jul 24 09:45 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jul 24 '23 Sale 47.83 1,570 75,087 67,180 Jul 24 09:45 PM
Index - P/E - EPS (ttm) -3.13 Insider Own 11.91% Shs Outstand 34.52M Perf Week 4.29%
Market Cap 21.78M Forward P/E - EPS next Y -1.81 Insider Trans -0.39% Shs Float 30.50M Perf Month -3.08%
Income -100.89M PEG - EPS next Q -0.57 Inst Own 16.27% Short Float 10.11% Perf Quarter -48.86%
Sales 15.30M P/S 1.42 EPS this Y 33.14% Inst Trans -24.29% Short Ratio 10.58 Perf Half Y -54.42%
Book/sh 1.66 P/B 0.38 EPS next Y 12.27% ROA -62.28% Short Interest 3.08M Perf Year -78.53%
Cash/sh 1.61 P/C 0.39 EPS next 5Y - ROE -106.46% 52W Range 0.57 - 3.90 Perf YTD -64.06%
Dividend Est. - P/FCF - EPS past 5Y - ROI -93.00% 52W High -83.87% Beta 2.62
Dividend TTM - Quick Ratio 4.52 Sales past 5Y 40.82% Gross Margin 1.80% 52W Low 9.97% ATR (14) 0.05
Dividend Ex-Date - Current Ratio 4.59 EPS Y/Y TTM 19.38% Oper. Margin -678.21% RSI (14) 44.97 Volatility 8.72% 7.62%
Employees 208 Debt/Eq 0.95 Sales Y/Y TTM 5.36% Profit Margin -659.57% Recom 2.20 Target Price 2.28
Option/Short Yes / Yes LT Debt/Eq 0.90 EPS Q/Q 40.39% Payout - Rel Volume 0.51 Prev Close 0.63
Sales Surprise -2.86% EPS Surprise 0.90% Sales Q/Q 31.06% Earnings Feb 29 AMC Avg Volume 291.50K Price 0.63
SMA20 1.40% SMA50 -15.58% SMA200 -57.95% Trades
Volume 147,623 Change -0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-22 Resumed Oppenheimer
Outperform
$48
Jun-14-22 Reiterated BTIG Research
Buy
$38 → $19
Jan-07-22 Initiated Stephens
Overweight
$26
Oct-15-21 Resumed Cowen
Outperform
$50
May-03-21 Initiated BTIG Research
Buy
$53
Jan-22-21 Initiated Oppenheimer
Outperform
$53
Dec-14-20 Initiated Craig Hallum
Buy
$23
Oct-30-20 Initiated William Blair
Outperform
Dec-05-19 Initiated Lake Street
Buy
Apr-18-24 04:15PM
Apr-01-24 04:05PM
Mar-08-24 08:05AM
Feb-29-24 04:01PM
Feb-13-24 08:05AM
04:30PM
Loading…
Jan-31-24 04:30PM
Jan-18-24 08:05AM
Jan-16-24 08:05AM
Jan-08-24 08:00AM
Dec-14-23 04:05PM
Nov-08-23 03:34PM
Nov-07-23 04:13PM
Nov-03-23 09:35AM
Nov-02-23 05:47PM
04:01PM
09:32AM
Loading…
Oct-23-23 09:32AM
Oct-18-23 03:55PM
Oct-12-23 08:05AM
Sep-21-23 04:05PM
Sep-19-23 08:05AM
Sep-13-23 05:55PM
Sep-11-23 08:05AM
Aug-31-23 09:40AM
Aug-25-23 08:05AM
Aug-09-23 09:06AM
Aug-03-23 05:35PM
04:01PM
Jul-19-23 08:00AM
Jul-17-23 08:00AM
Jul-13-23 07:43AM
08:00AM
Loading…
Jul-12-23 08:00AM
Jun-28-23 04:30PM
Jun-20-23 05:25AM
Jun-14-23 08:00AM
Jun-07-23 08:00AM
Jun-02-23 04:05PM
May-31-23 08:00AM
May-11-23 08:00AM
May-10-23 10:40AM
08:00AM
May-09-23 08:00AM
May-06-23 08:40AM
May-04-23 05:45PM
04:01PM
May-01-23 04:30PM
Apr-26-23 08:05AM
Apr-13-23 08:05AM
Apr-11-23 08:05AM
Apr-05-23 10:00AM
Apr-03-23 04:15PM
Mar-14-23 04:30PM
Mar-07-23 08:05AM
Mar-06-23 05:52AM
Mar-03-23 08:05AM
Mar-02-23 05:15PM
04:01PM
Feb-12-23 09:53AM
Feb-10-23 08:30AM
Feb-09-23 08:30AM
Jan-27-23 08:30AM
Jan-23-23 08:30AM
Jan-18-23 05:55AM
Jan-16-23 07:04AM
Jan-10-23 08:30AM
Jan-05-23 08:30AM
Dec-20-22 05:37AM
Dec-16-22 04:05PM
Nov-15-22 04:30PM
Nov-09-22 05:48AM
Nov-06-22 07:06AM
Nov-03-22 05:55PM
04:01PM
Oct-13-22 04:05PM
Oct-10-22 04:30PM
04:05PM
Oct-03-22 04:30PM
Sep-16-22 04:30PM
Sep-07-22 10:00AM
Aug-08-22 05:45PM
04:01PM
Aug-02-22 11:03AM
Aug-01-22 10:01AM
Jul-28-22 04:05PM
Jul-26-22 04:05PM
Jul-18-22 04:05PM
Jul-06-22 04:30PM
Jul-03-22 10:45AM
Jun-20-22 05:09AM
Jun-14-22 04:05PM
Jun-07-22 05:00PM
Jun-02-22 10:36AM
Jun-01-22 04:05PM
May-24-22 04:30PM
May-18-22 04:30PM
May-10-22 04:30PM
May-08-22 08:11PM
May-04-22 04:30PM
May-03-22 05:15PM
04:05PM
Apr-28-22 04:30PM
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sun Kevin M Chief Financial Officer Dec 11 '23 Sale 1.45 447 648 277,499 Dec 11 08:02 PM Ibarra Claudia Chief Operating Officer Dec 11 '23 Sale 1.45 331 480 193,547 Dec 11 08:02 PM Ibarra Claudia Chief Operating Officer Dec 08 '23 Sale 1.41 2,607 3,676 193,878 Dec 11 08:02 PM Sun Kevin M Chief Financial Officer Dec 07 '23 Sale 1.53 4,979 7,618 277,946 Dec 11 08:02 PM Ibarra Claudia Chief Operating Officer Dec 07 '23 Sale 1.53 3,911 5,984 196,485 Dec 11 08:02 PM Akhavan Ramin General Counsel Dec 07 '23 Sale 1.53 3,768 5,765 139,119 Dec 11 08:01 PM Sun Kevin M Chief Financial Officer Sep 11 '23 Sale 1.89 436 824 282,925 Sep 12 08:07 PM Ibarra Claudia Chief Operating Officer Sep 11 '23 Sale 1.89 322 609 200,396 Sep 12 08:06 PM Sun Kevin M Chief Financial Officer Sep 08 '23 Sale 1.93 9,180 17,717 283,361 Sep 12 08:07 PM Ibarra Claudia Chief Operating Officer Sep 08 '23 Sale 1.93 7,378 14,240 200,718 Sep 12 08:06 PM Akhavan Ramin General Counsel Sep 08 '23 Sale 1.93 4,531 8,745 142,887 Sep 12 08:04 PM Sun Kevin M Chief Financial Officer Jun 12 '23 Sale 2.85 437 1,245 290,041 Jun 14 08:16 PM Wood Todd Michael Chief Commercial Officer Jun 12 '23 Sale 2.85 350 998 284,757 Jun 14 08:17 PM Ibarra Claudia Chief Operating Officer Jun 12 '23 Sale 2.85 322 918 208,096 Jun 14 08:13 PM Sun Kevin M Chief Financial Officer Jun 08 '23 Sale 2.61 2,828 7,381 290,478 Jun 09 06:47 PM Ibarra Claudia Chief Operating Officer Jun 08 '23 Sale 2.61 2,371 6,188 208,418 Jun 09 06:47 PM Wood Todd Michael Chief Commercial Officer Jun 07 '23 Sale 2.53 4,992 12,630 285,107 Jun 09 06:52 PM Sun Kevin M Chief Financial Officer Jun 07 '23 Sale 2.53 4,988 12,620 293,306 Jun 09 06:47 PM Ibarra Claudia Chief Operating Officer Jun 07 '23 Sale 2.53 3,916 9,907 210,789 Jun 09 06:47 PM Akhavan Ramin General Counsel Jun 07 '23 Sale 2.53 3,776 9,553 147,418 Jun 09 06:46 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
